Evox Therapeutics appoints Dr David Lowe as Vice President of Research |
| October 13, 2020 | October 2020 Bond Updates |
|
OXFORD, England, Oct. 13, 2020 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce the appointment of Dr David Lowe as Vice President (VP) of Research. David will be overseeing the 40-person Research group with a... |
| View more at: https://www.prnewswire.com:443/news-releases/evox-therapeutics-appoints-dr-david-lowe-as-vice-president-of-research-301150518.html |
| Related News |
|